Adrenal Incidentalomas in Cancer Patients Are Not Always “Innocent”: A Case Report and Review of the Literature
Directory | PDF | Nursing | Cancer
Genotyping KRAS and EGFR Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment | Cancer Genomics & Proteomics
PDF) Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab: results from a European multicentre study
Hypertension management in cardio-oncology | Journal of Human Hypertension
ΔΗΜΟΣΙΕΥΣΕΙΣ | Ιωάννης Μούντζιος
Ανοσοθεραπεία του καρκίνου, η υπόσχεση του μέλλοντος. - Oncolife - Δρ. Ιωάννης Μούντζιος, Ογκολόγος - Παθολόγος
WCLC 2017 Program PDF | PDF | Medicine | Neoplasms
PDF) Unusual Sites of Metastatic Malignancy: CASE 1. Cardiac Metastasis in Hepatocellular Carcinoma | francesco cortese and Francesco Torino - Academia.edu
Cancers | Free Full-Text | A Real-World, Observational, Prospective Study to Assess the Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations upon Progression on or after First-Line Therapy with a First-
PDF) Cardioprotective Strategies from Cardiotoxicity in Cancer Patients: A Comprehensive Review
Hypertension management in cardio-oncology | Journal of Human Hypertension
Insulin-Like Growth Factor 1 Receptor (IGF1R) Expression and Survival in Operable Squamous-Cell Laryngeal Cancer | PLOS ONE
PDF) A Real-World, Observational, Prospective Study to Assess the Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations upon Progression on or after First-Line Therapy with a First or Second Generation EGFR
PDF) An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with
PDF) A Real-World, Observational, Prospective Study to Assess the Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations upon Progression on or after First-Line Therapy with a First- or Second-Generation EGFR Tyrosine
Giannis MOUNTZIOS | Consultant Medical Oncologist | Consultant Medical Oncologist | National and Kapodistrian University of Athens, Athens | uoa | Medical Oncology | Research profile
27 Hellenic Conference of Clinical Oncology
Giannis MOUNTZIOS | Consultant Medical Oncologist | Consultant Medical Oncologist | National and Kapodistrian University of Athens, Athens | uoa | Medical Oncology | Research profile
PDF) Treating EGFR-Mutated Oncogene-Addicted Advanced Non-Small-Cell Lung Cancer in the Era of Economic Crisis in Greece: Challenges and Opportunities
PDF) Lessons from the past: Long-term safety and survival outcomes of a prematurely terminated randomized controlled trial on prophylactic vs. hemoglobin-based administration of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia
Ramon Andrade de Mello Álvaro Tavares Giannis Mountzios Editors (iMOP) - Principles of Medical Oncology
Giannis MOUNTZIOS | Consultant Medical Oncologist | Consultant Medical Oncologist | National and Kapodistrian University of Athens, Athens | uoa | Medical Oncology | Research profile
PDF) Lessons from the past: Long-term safety and survival outcomes of a prematurely terminated randomized controlled trial on prophylactic vs. hemoglobin-based administration of erythropoiesis-stimulating agents in patients with chemotherapy-induced ...
Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 15 Issue 4 (2017)
Η ογκολογία ακριβείας μεταμορφώνει τις αντικαρκινικές θεραπείες - Oncolife - Δρ. Ιωάννης Μούντζιος, Ογκολόγος - Παθολόγος
